BioMarin Pharmaceutical Inc.
BMRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,744 | $426,218 | $185,686 | $124,943 |
| Dep. & Amort. | $18,487 | $18,563 | $22,069 | $23,607 |
| Deferred Tax | -$13,646 | $33,342 | $28,429 | $42,387 |
| Stock-Based Comp. | $0 | $47,531 | $37,700 | $51,919 |
| Change in WC | $118,927 | -$158,073 | -$90,462 | -$83,151 |
| Other Non-Cash | $275,661 | -$182,310 | -$9,028 | $25,922 |
| Operating Cash Flow | $368,685 | $185,271 | $174,394 | $185,627 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$33,750 | -$17,101 | -$16,768 | -$19,530 |
| Net Acquisitions | -$285,193 | $0 | $0 | $0 |
| Inv. Purchases | -$110,829 | -$113,159 | -$89,274 | -$57,879 |
| Inv. Sales/Matur. | $98,809 | $117,934 | $77,804 | $154,582 |
| Other Inv. Act. | $0 | -$266 | $0 | -$769 |
| Investing Cash Flow | -$330,963 | -$12,592 | -$28,238 | $76,404 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7 | $7,707 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$38,779 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,176 | -$12,310 | $0 | $2,859 |
| Financing Cash Flow | -$2,169 | -$4,603 | -$38,779 | $2,859 |
| Forex Effect | $739 | -$3,063 | -$1,416 | $2,504 |
| Net Chg. in Cash | $36,292 | $165,013 | $105,961 | $267,394 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,213,816 | $1,048,803 | $942,842 | $675,448 |
| End Cash | $1,250,108 | $1,213,816 | $1,048,803 | $942,842 |
| Free Cash Flow | $340,238 | $168,170 | $157,626 | $165,328 |